Vernal Biosciences Funding: $43M Raised, Series A (2023)
Vernal Biosciences is based in Burlington, VT. It has raised $43M in total funding. Latest round: Series A.
Vernal Biosciences funding overview
Vernal Biosciences is based in Burlington, VT. Vernal Biosciences has raised $43M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2023. The round record for Vernal Biosciences runs through 2023; nothing later has been disclosed. Investors on record include Ampersand Capital Partners, Charles River Labs, Dynamk Capital, Vermont Center for Emerging Technologies. 4 distinct backers are named across the disclosed rounds.
Vernal Biosciences at a glance
Total raised
$43M
Latest round
Series A
Latest round date
June 2023
Headquarters
Burlington, VT
Notable investors
Ampersand Capital Partners, Charles River Labs, Dynamk Capital, Vermont Center for Emerging Technologies
Frequently asked about Vernal Biosciences funding
How much has Vernal Biosciences raised?
Vernal Biosciences has raised $43M in total disclosed funding across the rounds on record.
Who has invested in Vernal Biosciences?
Ampersand Capital Partners, Charles River Labs, Dynamk Capital, Vermont Center for Emerging Technologies are named among the investors backing Vernal Biosciences.
What was the latest Vernal Biosciences funding round?
The most recent disclosed round is a Series A, announced in June 2023.
Where is Vernal Biosciences based?
Vernal Biosciences is based in Burlington, VT.
When did Vernal Biosciences last raise?
The last disclosed Vernal Biosciences round closed in June 2023 at Series A.
Vernal Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Burlington below to benchmark round size and investor mix.
